CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
| CVRX Stock | USD 12.67 0.10 0.78% |
Slightly above 62% of CVRx's investor base is looking to short. The analysis of overall sentiment of trading CVRx Inc stock suggests that many investors are alarmed at this time. CVRx's investing sentiment can be driven by a variety of factors including economic data, CVRx's earnings reports, geopolitical events, and overall market trends.
CVRx |
New data published in JACC Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12, 2024 -- CVRx, Inc. , a commercial-stage medical device company, announced today the publication of new data in the Journal of the American College of Cardiology Heart Failure. The data detail the durable improvements out to 24-months in the individual components o
Read at finance.yahoo.com
 |
CVRx Fundamental Analysis
We analyze CVRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
CVRx is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
CVRx Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CVRx stock to make a market-neutral strategy. Peer analysis of CVRx could also be used in its relative valuation, which is a method of valuing CVRx by comparing valuation metrics with similar companies.
Peers
CVRx Related Equities
| AXDX | Accelerate Diagnostics | 4.35 | ||||
| NPCE | Neuropace | 2.94 | ||||
| KIDS | Orthopediatrics Corp | 2.70 | ||||
| LIVN | LivaNova PLC | 1.33 | ||||
| ANIK | Anika Therapeutics | 1.29 | ||||
| LUNG | Pulmonx Corp | 1.19 | ||||
| SRDX | SurModics | 0.20 | ||||
| AXGN | Axogen | 0.06 | ||||
| OFIX | Orthofix Medical | 0.23 | ||||
| AORT | Artivion | 1.41 | ||||
| SGHT | Sight Sciences | 1.65 | ||||
| ELMD | Electromed | 2.02 |
Additional Tools for CVRx Stock Analysis
When running CVRx's price analysis, check to measure CVRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVRx is operating at the current time. Most of CVRx's value examination focuses on studying past and present price action to predict the probability of CVRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVRx's price. Additionally, you may evaluate how the addition of CVRx to your portfolios can decrease your overall portfolio volatility.